GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (UKEX:JNJ) » Definitions » E10

Johnson & Johnson (UKEX:JNJ) E10 : ₴273.68 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Johnson & Johnson E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2024 was ₴53.809. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₴273.68 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Johnson & Johnson's average E10 Growth Rate was 17.00% per year. During the past 3 years, the average E10 Growth Rate was 13.10% per year. During the past 5 years, the average E10 Growth Rate was 8.60% per year. During the past 10 years, the average E10 Growth Rate was 4.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Johnson & Johnson was 16.60% per year. The lowest was -0.10% per year. And the median was 12.00% per year.

As of today (2024-05-24), Johnson & Johnson's current stock price is ₴5947.00. Johnson & Johnson's E10 for the quarter that ended in Mar. 2024 was ₴273.68. Johnson & Johnson's Shiller PE Ratio of today is 21.73.

During the past 13 years, the highest Shiller PE Ratio of Johnson & Johnson was 33.32. The lowest was 19.28. And the median was 25.92.


Johnson & Johnson E10 Historical Data

The historical data trend for Johnson & Johnson's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson E10 Chart

Johnson & Johnson Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 223.12 274.32

Johnson & Johnson Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 251.85 239.26 292.14 274.32 273.68

Competitive Comparison of Johnson & Johnson's E10

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.



Johnson & Johnson E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=53.809/131.7762*131.7762
=53.809

Current CPI (Mar. 2024) = 131.7762.

Johnson & Johnson Quarterly Data

per share eps CPI Adj_EPS
201406 60.636 100.560 79.459
201409 66.659 100.428 87.467
201412 35.739 99.070 47.538
201503 61.439 99.621 81.270
201506 64.651 100.684 84.616
201509 48.187 100.392 63.251
201512 46.180 99.792 60.981
201603 63.848 100.470 83.743
201606 57.423 101.688 74.414
201609 61.439 101.861 79.483
201612 55.415 101.863 71.688
201703 64.651 102.862 82.824
201706 56.219 103.349 71.683
201709 55.014 104.136 69.616
201712 -160.223 104.011 -202.994
201803 64.250 105.290 80.413
201806 58.226 106.317 72.169
201809 57.825 106.507 71.544
201812 44.975 105.998 55.913
201903 55.817 107.251 68.581
201906 83.525 108.070 101.847
201909 26.503 108.329 32.239
201912 60.234 108.420 73.210
202003 87.139 108.902 105.442
202006 54.612 108.767 66.165
202009 53.408 109.815 64.089
202012 26.101 109.897 31.297
202103 93.162 111.754 109.853
202106 94.367 114.631 108.481
202109 55.014 115.734 62.639
202112 71.076 117.630 79.624
202203 77.501 121.301 84.194
202206 72.281 125.017 76.189
202209 67.462 125.227 70.990
202212 53.408 125.222 56.203
202303 -1.205 127.348 -1.247
202306 78.706 128.729 80.569
202309 409.994 129.860 416.045
202312 67.061 129.419 68.282
202403 53.809 131.776 53.809

Add all the adjusted EPS together and divide 10 will get our e10.


Johnson & Johnson  (UKEX:JNJ) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=5947.00/273.68
=21.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Johnson & Johnson was 33.32. The lowest was 19.28. And the median was 25.92.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Johnson & Johnson E10 Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson (UKEX:JNJ) Business Description

Address
One Johnson and Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.